Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study.
Saved in:
| Title: | Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study. |
|---|---|
| Authors: | Jindal T; University of California San Francisco, Helen Diller Family Cancer Center, San Francisco, CA., Jiang CY; University of Texas, MD Anderson Cancer Center, Houston, TX., Alhalabi O; University of Texas, MD Anderson Cancer Center, Houston, TX., Davidsohn M; Dana Farber Cancer Center, Boston, MA., Freeman D; Dana Farber Cancer Center, Boston, MA., Epstein IY; Dana Farber Cancer Center, Boston, MA., Bakaloudi DR; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Talukder R; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Nizam A; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Nguyen CB; University of Michigan Rogel Comprehensive Cancer Center, Ann Arbor, MI., Oh E; University of Michigan Rogel Comprehensive Cancer Center, Ann Arbor, MI., Tsung I; University of Michigan Rogel Comprehensive Cancer Center, Ann Arbor, MI., Glover MJ; Stanford University, Stanford, CA., Khaki AR; Stanford University, Stanford, CA., Taylor AK; University of Wisconsin Carbone Cancer Center, Madison, WI., Jaime-Casas S; City of Hope Comprehensive Cancer Center, Duarte, CA., Jang A; University Hospitals Seidman Cancer Center, Cleveland, OH., Lemke E; Froedtert and the Medical College of Wisconsin Clinical Cancer Center, Milwaukee, WI., Pywell C; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL., Evans ST; Winship Cancer Institute of Emory University, Atlanta, GA., Shin D; Winship Cancer Institute of Emory University, Atlanta, GA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA., Basu A; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL., Kilari D; Froedtert and the Medical College of Wisconsin Clinical Cancer Center, Milwaukee, WI., Tripathi A; City of Hope Comprehensive Cancer Center, Duarte, CA., Brown J; University Hospitals Seidman Cancer Center, Cleveland, OH., Emamekhoo H; University of Wisconsin Carbone Cancer Center, Madison, WI., Davis NB; Vanderbilt-Ingram Cancer Center, Nashville, TN., Shah S; Stanford University, Stanford, CA., Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Grivas P; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA., Bellmunt J; Dana Farber Cancer Center, Boston, MA., Alva A; Stanford University, Stanford, CA., Campbell MT; University of Texas, MD Anderson Cancer Center, Houston, TX., Koshkin VS; University of California San Francisco, Helen Diller Family Cancer Center, San Francisco, CA. Electronic address: Vadim.koshkin@ucsf.edu. |
| Source: | Urologic oncology [Urol Oncol] 2026 Jan; Vol. 44 (1), pp. 65.e1-65.e11. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
